•Morpheus Research alleges MakeMyTrip continues anti-competitive price parity practices despite a 2022 penalty from the Competition Commission of India (CCI).
•The report alleges accounting irregularities and the use of misleading financial metrics by the company.
•The report claims there is an undisclosed CCI investigation due in early 2026.
•Vital Farms faces a class action lawsuit alleging it misled investors about the risks and impact of delays in its new Enterprise Resource Planning (ERP) system.
•The lawsuit, filed by Bragar Eagel & Squire, claims the company downplayed issues, leading to missed earnings and investor losses.
•The lawsuit covers investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026.
•Maase Inc. (NASDAQ: MAAS) completed the acquisition of 100% equity interests in Times Good Limited, which controls the Huazhi Group.
•The transaction was officially consummated on March 30, 2026, following its initial disclosure in January 2026.
•The acquisition marks a strategic shift for the company from a 'Scenario Operator' to an 'AI Industry Player' with full-stack, self-controlled capabilities.
